An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach

Area of Science:

• Oncology
• Medical Genetics

Background:

• Metastatic epidermal growth factor receptor (EGFR) mutation-positive (EGFR-M+) non-small-cell lung cancer (NSCLC) treatment is complex.
• Evolving therapeutic landscape necessitates personalized treatment strategies.

Purpose of the Study:

• To present a stepwise approach for personalizing EGFR-M+ NSCLC treatment.
• To address real-world challenges in treatment decision-making for physicians.

Main Methods:

• Review of decision criteria for first-line therapy selection.
• Emphasis on repeat biopsy importance for guiding subsequent therapies.
• Discussion of third-line and beyond treatment options.

Main Results:

• A personalized, stepwise treatment approach is outlined.
• An algorithm is proposed to optimize sequencing strategies.
• Consideration of factors influencing treatment decisions is highlighted.

Conclusions:

• Personalized sequencing of therapies can prolong survival in EGFR-M+ NSCLC.
• Optimizing treatment sequences maintains patient quality of life.
• Repeat biopsies are crucial for effective treatment adaptation.